Setmelanotide in patients aged 2–5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial

2024/11/13 by Jesús Argente, Charles F. Verge, Charles F Verge +10 · 1 voice
Medicine · Neuroscience · #Adipokines, Inflammation, and Metabolic Diseases #Adipose Tissue and Metabolism #Regulation of Appetite and Obesity

paper · doi:10.1016/s2213-8587(24)00273-0

openalex publication_date 2024/11/13 · crossref created 2024/11/13 · crossref issued 2025/01/01 · crossref published 2025/01/01 · crossref published-print 2025/01/01 · crossref deposited 2025/02/18 · openalex created_date 2025/10/10 · crossref indexed 2026/07/23 · openalex updated_date 2026/07/25

Citations

• Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions

Discussions

• @ims-mrl.bsky.social researchers are exploring how weight loss-through diet, precision medication, or surgery-can improve long-term health outcomes in children and adults. The Farooqi lab and colleagu [bsky, 1 points, 0 comments]